Search

Your search keyword '"Vrancken Peeters, Marie-Jeanne T. F. D."' showing total 256 results
Start Over Author "Vrancken Peeters, Marie-Jeanne T. F. D."
256 results on '"Vrancken Peeters, Marie-Jeanne T. F. D."'

4. High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial

Author

Vliek, Sonja, Hilbers, Florentine S., van Werkhoven, Erik, Mandjes, Ingrid, Kessels, Rob, Kleiterp, Sieta, Lips, Esther H., Mulder, Lennart, Kayembe, Mutamba T., Loo, Claudette E., Russell, Nicola S., Vrancken Peeters, Marie-Jeanne T. F. D., Holtkamp, Marjo J., Schot, Margaret, Baars, Joke W., Honkoop, Aafke H., Vulink, Annelie J. E., Imholz, Alex L. T., Vrijaldenhoven, Suzan, van den Berkmortel, Franchette W. P. J., Meerum Terwogt, Jetske M., Schrama, Jolanda G., Kuijer, Philomeen, Kroep, Judith R., van der Padt-Pruijsten, Annemieke, Wesseling, Jelle, Sonke, Gabe S., Gilhuijs, Kenneth G. A., Jager, Agnes, Nederlof, Petra, and Linn, Sabine C.

Published
2023
Full Text
View/download PDF

5. MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study

Author

van Leeuwen-Stok, E., van Leeuwen, L., de Graaf, H., van Riel, J.M.G.H., Houtsma, D., Vrijaldenhoven, S., van der Velden, A.W.G., Peerdeman, A.L., van den Brink - Schimmel, R.J., Drooger, J.C., Imholz, A.L.Th., Dercksen, M.W., Oulad Hadj, J., Bakker, S.D., van der Wouw, A.J., Kerver, E.D., Bouma, G., van Schaik, C., de Boer, M., Mandigers, C.M.P.W., Koornstra, R.H.T., Smals, A., Rietbroek, R.C., van der Padt - Pruijsten, A., den Boer, M.O., Bos, H., Schiphorst, P.P.J.B.M., Vriens, B.E.P.J., van Rossum, Q.C., Tol, J., Hoogwerf - Kluft, D., Kruijtzer - Schimmel, C.M.F., Oosterkamp, H.M., Baas, I.O., Dietvorst, A.H.P., Davidis - van Schoonhoven, M., van Dijk, M.A., van der Voort, Anna, Louis, Fleur M, van Ramshorst, Mette S, Kessels, Rob, Mandjes, Ingrid A, Kemper, Inge, Agterof, Mariette J, van der Steeg, Wim A, Heijns, Joan B, van Bekkum, Marlies L, Siemerink, Ester J, Kuijer, Philomeen M, Scholten, Astrid, Wesseling, Jelle, Vrancken Peeters, Marie-Jeanne T F D, Mann, Ritse M, and Sonke, Gabe S

Published
2024
Full Text
View/download PDF

9. Changes in breast cancer treatment during the COVID-19 pandemic: a Dutch population-based study

Author

Eijkelboom, Anouk H., de Munck, Linda, Menke-van der Houven van Oordt, C. Willemien, Broeders, Mireille J. M., van den Bongard, Desiree H. J. G., Strobbe, Luc J. A., Mureau, Marc A. M., Lobbes, Marc B. I., Westenend, Pieter J., Koppert, Linetta B., Jager, Agnes, Siemerink, Ester J. M., Wesseling, Jelle, Verkooijen, Helena M., Vrancken Peeters, Marie-Jeanne T. F. D., Smidt, Marjolein L., Tjan-Heijnen, Vivianne C. G., and Siesling, Sabine

Published
2023
Full Text
View/download PDF

11. Margin assessment during breast conserving surgery using diffuse reflectance spectroscopy

Author

Veluponnar, Dinusha, primary, de Boer, Lisanne L., additional, Dashtbozorg, Behdad, additional, Jong, Lynn-Jade S., additional, Geldof, Freija, additional, Guimaraes, Marcos Da Silva, additional, Sterenborg, Henricus J. C. M., additional, Vrancken-Peeters, Marie-Jeanne T. F. D., additional, van Duijnhoven, Frederieke, additional, and Ruers, Theo, additional

Published
2024
Full Text
View/download PDF

16. Breast-Conserving Therapy in Patients with cT3 Breast Cancer with Good Response to Neoadjuvant Systemic Therapy Results in Excellent Local Control: A Comprehensive Cancer Center Experience

Author

van der Noordaa, Marieke E. M., Ioan, Ileana, Rutgers, Emiel J., van Werkhoven, Erik, Loo, Claudette E., Voorthuis, Rosie, Wesseling, Jelle, van Urk, Japke, Wiersma, Terry, Dezentje, Vincent, Vrancken Peeters, Marie-Jeanne T. F. D., and van Duijnhoven, Frederieke H.

Published
2021
Full Text
View/download PDF

19. Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study

Author

van Loevezijn, Ariane A., van der Noordaa, Marieke E.M., van Werkhoven, Erik D., Loo, Claudette E., Winter-Warnars, Gonneke A. O., Wiersma, Terry, van de Vijver, Koen K., Groen, Emilie J., Blanken-Peeters, Charlotte F. J. M., Zonneveld, Bas J.G.L., Sonke, Gabe S., van Duijnhoven, Frederieke H., and Vrancken Peeters, Marie-Jeanne T. F. D.

Published
2021
Full Text
View/download PDF

23. Diffuse reflectance spectroscopy for accurate margin assessment in breast-conserving surgeries: importance of an optimal number of fibers

Author

Veluponnar, Dinusha, primary, Dashtbozorg, Behdad, additional, Jong, Lynn-Jade S., additional, Geldof, Freija, additional, Da Silva Guimaraes, Marcos, additional, Vrancken Peeters, Marie-Jeanne T. F. D., additional, van Duijnhoven, Frederieke, additional, Sterenborg, Henricus J. C. M., additional, Ruers, Theo J. M., additional, and de Boer, Lisanne L., additional

Published
2023
Full Text
View/download PDF

27. Toward Intraoperative Margin Assessment Using a Deep Learning-Based Approach for Automatic Tumor Segmentation in Breast Lumpectomy Ultrasound Images

Author

Veluponnar, Dinusha, primary, de Boer, Lisanne L., additional, Geldof, Freija, additional, Jong, Lynn-Jade S., additional, Da Silva Guimaraes, Marcos, additional, Vrancken Peeters, Marie-Jeanne T. F. D., additional, van Duijnhoven, Frederieke, additional, Ruers, Theo, additional, and Dashtbozorg, Behdad, additional

Published
2023
Full Text
View/download PDF

29. Revision Incidence after Immediate Direct-to-Implant versus Two-Stage Implant-Based Breast Reconstruction Using National Real-World Data

Author

Becherer, Babette E., Heeg, Erik, Young-Afat, Danny A., Vrancken Peeters, Marie-Jeanne T. F. D., Rakhorst, Hinne A., Mureau, Marc A. M., Plastic and Reconstructive Surgery and Hand Surgery, Plastic, Reconstructive and Hand Surgery, and Surgery

Abstract

Background: In immediate implant-based breast reconstruction (IBBR), large variation is observed in current practices between a direct-to-implant and a two-stage approach (insertion of a breast implant after a tissue expander). This population-based study aimed to compare unplanned short- and long-term revision incidence between direct-to-implant and two-stage IBBR in The Netherlands. Methods: All patients who underwent immediate IBBR following a mastectomy between 2015 and 2019 were selected from the nationwide Dutch Breast Implant Registry. Short- and long-term unplanned revision incidences were studied per immediate IBBR, including revision indications and the total number of additional operations. Confounding by indication was limited using propensity score matching. Results: A total of 4512 breast implants (3948 women) were included, of which 2100 (47%) were for direct-to-implant IBBR and 2412 (53%) were for two-stage IBBR. Median (IQR) follow-up was 29 months (range, 16 to 45 months) and 33 months (range, 21 to 47 months), respectively. Short-term revision incidence was 4.0% and 11.7%, respectively (conditional OR, 0.31; 95% CI, 0.23 to 0.42%). Long-term revision incidence was 10.6% (95% CI, 9.2 to 12.1%) and 16.4% (95% CI, 14.8 to 17.9%), respectively. In the propensity score-matched cohort, similar results were found. In the direct-to-implant group, more breasts were reconstructed within the planned number of operations than in the two-stage group. Conclusions: Unplanned revision surgery occurred less often after direct-to-implant IBBR, and more breasts were reconstructed within the planned number of operations compared to two-stage IBBR. These results, based on real-world data, are important for improving patient counseling and shared decision-making. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, II.

Published
2023

31. The Safe Use of 125 I-Seeds as a Localization Technique in Breast Cancer during Pregnancy.

Author

Heeling, Eva, van de Kamer, Jeroen B., Methorst, Michelle, Bruining, Annemarie, van de Meent, Mette, Vrancken Peeters, Marie-Jeanne T. F. D., Lok, Christianne A. R., and van der Ploeg, Iris M. C.

Subjects
ONCOLOGIC surgery, CONFIDENCE intervals, PREGNANT women, GESTATIONAL age, RADIATION, RETROSPECTIVE studies, CANCER patients, IODINE radioisotopes, COMPARATIVE studies, PREGNANCY complications, RADIATION doses, HEALTH, DESCRIPTIVE statistics, LUMPECTOMY, RADIOISOTOPE brachytherapy, DATA analysis software, BREAST tumors, PATIENT safety, ONCOLOGISTS, PREGNANCY
Abstract

Simple Summary: The results of this multidisciplinary study can function as a clinician's guide for determining the preferred surgical localization technique for breast-conserving surgery in pregnant women with breast cancer and its timing, without avoiding the use of a 125I-seed. The maximum exposure to the fetus remains well below 100 millisieverts (mSv), the threshold value for tissue damage caused by radiation. If the exposure should remain below 1 mSv, the implantation and surgical removal of the 125I-seed should occur within two weeks after a GA of 26 weeks, and within one week after a GA of 32 weeks. The contribution of an axillary seed is negligible (at maximum, 2.3% of the seed implanted in the breast). Introduction: Some aspects of the treatment protocol for breast cancer during pregnancy (PrBC) have not been thoroughly studied. This study provides clarity regarding the safety of the use of 125I-seeds as a localization technique for breast-conserving surgery in patients with PrBC. Methods: To calculate the exposure to the fetus of one 125I-seed implanted in a breast tumor, we developed a model accounting for the decaying 125I-source, time to surgery, and the declining distance between the 125I-seed and the fetus. The primary outcome was the maximum cumulative fetal dose of radiation at consecutive gestational ages (GA). Results: The cumulative fetal dose remains below 1 mSv if a single 125I-seed is implanted at a GA of 26 weeks. After a GA of 26 weeks, the fetal dose can be at a maximum of 11.6 mSv. If surgery takes place within two weeks of implantation from a GA of 26 weeks, and one week above a GA of 32 weeks, the dose remains below 1 mSv. Conclusion: The use of 125I-seeds is safe in PrBC. The maximum fetal exposure remains well below the threshold of 100 mSv, and therefore, does not lead to an increased risk of fetal tissue damage. Still, we propose keeping the fetal dose as low as possible, preferably below 1 mSv. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

34. Discriminating healthy from tumor tissue in breast lumpectomy specimens using deep learning-based hyperspectral imaging

Author

Jong, Lynn-Jade S., primary, de Kruif, Naomi, additional, Geldof, Freija, additional, Veluponnar, Dinusha, additional, Sanders, Joyce, additional, Vrancken Peeters, Marie-Jeanne T. F. D., additional, van Duijnhoven, Frederieke, additional, Sterenborg, Henricus J. C. M., additional, Dashtbozorg, Behdad, additional, and Ruers, Theo J. M., additional

Published
2022
Full Text
View/download PDF

35. Additional file 1 of Transparency in quality of radiotherapy for breast cancer in the Netherlands: a national registration of radiotherapy-parameters

Author

Maliko, Nansi, Stam, Marcel R., Boersma, Liesbeth J., Vrancken Peeters, Marie-Jeanne T. F. D., Wouters, Michel W. J. M., KleinJan, Eline, Mulder, Maurice, Essers, Marion, Hurkmans, Coen W., and Bijker, Nina

Subjects
nervous system, mental disorders, psychological phenomena and processes, nervous system diseases
Abstract

Additional file 1. Example of a mapping table to map ROI names to variable names. CT-scan, computed tomography scan; Gy, Gray; SIB, simultaneous integrated boost In order to let departments use their own ROIs names they had to fill out a mapping table. a. ROIs descriptions mentioned in the table are examples and may differ per institution b. Based on the average dose calculated in the ROIs and if within certain ranges, mapped to prescribed dose c. Based on total dose in the boost PTV (SIB: elective + boost dose; sequential: boost dose).

Published
2022
Full Text
View/download PDF

40. Additional file 1 of [18F]FDG-PET/CT in prone compared to supine position for optimal axillary staging and treatment in clinically node-positive breast cancer patients with neoadjuvant systemic therapy

Author

van Loevezijn, Ariane A., Stokkel, Marcel P. M., Donswijk, Maarten L., van Werkhoven, Erik D., van der Noordaa, Marieke E. M., van Duijnhoven, Frederieke H., and Vrancken Peeters, Marie-Jeanne T. F. D.

Abstract

Additional file 1. Table S1. Number of patients categorized in the same axillary staging groups with FDG-PET/CT in supine and prone position by both observers.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results